Anti-Infective Agents
SJR0.199
AE
AEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.199 | Q4 | 27.6% | |
| 2024 | — | — | 0.167 | Q4 | 23.9% | |
| 2023 | — | — | 0.178 | Q4 | 30.9% | |
| 2022 | — | — | 0.159 | Q4 | 30.2% | |
| 2021 | — | — | 0.160 | Q4 | 32.4% | |
| 2020 | — | — | 0.178 | Q4 | 30.5% | |
| 2019 | — | — | 0.155 | Q4 | 29.2% | |
| 2018 | — | — | 0.144 | Q4 | 20.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2211-3525
ISSN
2211-3533
country
AEcoverage
2012-2026